Gene Expression Signature–Based Prognostic Risk Score in Gastric Cancer

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinical Cancer Research

• Publication date

  2011-03-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-10-2180PMID 21447720PMCID PMC3078023
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  2011cited by this paper
• Treatment of resectable gastric cancer: current standards of care

  2009cited by this paper
• Who needs adjuvant systemic treatment ? Predicting prognosis in node-negative breast cancer ; from bench to bedside

  2009cited by this paper
• Integrated gene copy number and expression microarray analysis of gastric cancer highlights potential target genes

  2008cited by this paper
• Analysis of Gene Expression Data Using BRB-Array Tools

  2007cited by this paper
• A five-gene signature and clinical outcome in non-small-cell lung cancer.

  2007cited by this paper
• Topoisomerase IIα gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study

  2006cited by this paper
• A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells

  2006cited by this paper
• Technology Insight: tuning into the genetic orchestra using microarrays—limitations of DNA microarrays in clinical practice

  2006cited by this paper
• Molecular Dissection of 17q12 Amplicon in Upper Gastrointestinal Adenocarcinomas

  2006cited by this paper
• Topoisomerase IIalpha gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study.

  2006cited by this paper
• Survival Model Predictive Accuracy and ROC Curves

  2005cited by this paper
• Perspectives in the treatment of gastric cancer

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

  2004cited by this paper
• Concise prediction models of anticancer efficacy of 8 drugs using expression data from 12 selected genes

  2004cited by this paper
• Application of comparative functional genomics to identify best-fit mouse models to study human cancer

  2004cited by this paper
• A combined comparative genomic hybridization and expression microarray analysis of gastric cancer reveals novel molecular subtypes.

  2003cited by this paper
• Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification.

  2003cited by this paper
• A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

  2003cited by this paper
• Genomic profiling of gastric cancer predicts lymph node status and survival

  2003cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• A gene-expression signature as a predictor of survival in breast cancer.

  2002cited by this paper
• beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer.

  2002cited by this paper
• Expression patterns of Wnt genes in mouse gut development.

  2001cited by this paper
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

  2000cited by this paper
• The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy

  2000cited by this paper
• Cluster analysis and display of genome-wide expression patterns.

  1998cited by this paper
• Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival.

  1997cited by this paper
• Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer.

  1992cited by this paper
• Patterns of failure following curative resection of gastric carcinoma.

  1990cited by this paper
• Lymph node metastases of gastric cancer. General pattern in 1931 patients.

  1989cited by this paper
• Prognostic factors in stomach cancer surgery.

  1986cited by this paper

• The Role of CCR1 as a decisive factor for immune response activation versus suppression phenotypes in gastric cancer

  2026cites this paper
• Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer.

  2026cites this paper
• An inherited predisposition allele promotes gastric cancer via enhancing deubiquitination-mediated activation of epithelial-to-mesenchymal transition signaling

  2025cites this paper
• PI3 expression predicts recurrence after chemotherapy with DNA‐damaging drugs in gastric cancer

  2025cites this paper
• Multi-omics analysis identifies diagnostic circulating biomarkers and potential therapeutic targets, revealing IQGAP1 as an oncogene in gastric cancer

  2025cites this paper
• Integrative machine learning reveals the biological function and prognostic significance of α-ketoglutarate in gastric cancer

  2025influential citation
• Metabolic and aging related gene risk score for therapeutic stratification and precision oncology in gastric cancer

  2025cites this paper
• Increased Expression of RCN1P2, TPM3P9, and HSP90AB3P as Non-Coding RNA in Gastric Cancer Linked to Proliferative, Inflammatory and Metastatic Pathways through a Competing Endogenous RNAs Network

  2025cites this paper
• Tumor Immune Contexture Model Predicts Prognosis and Immunotherapy Response in Gastric Cancer

  2025cites this paper
• Evaluating the Potential of COL8A1 as a Therapeutic Target for Chemoresistance, Disease Progression, and a Prognostic Marker in Gastric Cancer

  2025cites this paper
• COL1A1-positive endothelial cells promote gastric cancer progression via the ANGPTL4-SDC4 axis driven by Endothelial-to-Mesenchymal Transition.

  2025cites this paper
• Multi-omics unravel heterogeneity of glucose metabolism reprogramming in gastric cancer

  2025cites this paper
• The tumour microenvironment score outperforms established molecular classifiers as a prognostic factor for disease-free interval and disease-specific survival in non-metastatic gastric cancer

  2025cites this paper
• A Novel Transcriptomic Signature for Prediction of Response to Adjuvant Chemotherapy in Patients With Stages II and III Gastric Cancer

  2025cites this paper
• Molecular classification and intratumoral heterogeneity of gastric adenocarcinoma

  2024cites this paper
• Representing ECM composition and EMT pathways in gastric cancer using a new metastatic gene signature

  2024cites this paper
• A novel M2-like tumor associated macrophages-related gene signature for predicting the prognosis and immunotherapy efficacy in gastric cancer

  2024cites this paper
• Spatial dissection of tumour microenvironments in gastric cancers reveals the immunosuppressive crosstalk between CCL2+ fibroblasts and STAT3-activated macrophages

  2024cites this paper
• Unraveling the regulatory cell death pathways in gastric cancer: a multi-omics study

  2024cites this paper
• Evaluations of Biomarkers CDX1 and CDX2 in Gastric Cancer Prognosis: A Meta-analysis

  2024cites this paper
• HSPA4 upregulation induces immune evasion via ALKBH5/CD58 axis in gastric cancer

  2024cites this paper
• Identification of a novel gene signature related to prognosis and metastasis in gastric cancer

  2024cites this paper
• The Tumour Immune Microenvironment Drives Survival Outcomes and Therapeutic Response in an Integrated Molecular Analysis of Gastric Adenocarcinoma.

  2024cites this paper
• ESM1 facilitates the EGFR/HER3-triggered epithelial-to-mesenchymal transition and progression of gastric cancer via modulating interplay between Akt and angiopoietin-2 signaling

  2024cites this paper
• Transcriptomic study of gastrointestinal stromal tumors with liver metastasis

  2023cites this paper
• Bioinformatic Analysis of PTTG Family and Prognosis and Immune Cell Infiltration in Gastric Cancer

  2023cites this paper
• A prediction model for prognosis of gastric adenocarcinoma based on six metabolism-related genes

  2023cites this paper
• TMBIM6-mediated miR-181a expression regulates breast cancer cell migration and invasion via the MAPK/ERK signaling pathway

  2023cites this paper
• A Novel Gene List Identifies Tumors with a Stromal-Mesenchymal Phenotype and Worse Prognosis in Gastric Cancer

  2023influential citation
• Microdissection of cancer-associated fibroblast infiltration subtypes unveils the secreted SERPINE2 contributing to immunosuppressive microenvironment and immuotherapeutic resistance in gastric cancer: A large-scale study integrating bulk and single-cell transcriptome profiling

  2023cites this paper
• Gastric cancer peritoneal metastasis related signature predicts prognosis and sensitivity to immunotherapy in gastric cancer

  2023cites this paper
• Identification of INHBA as a potential biomarker for gastric cancer through a comprehensive analysis

  2023cites this paper
• Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in gastric cancer

  2023cites this paper
• Genomic analysis of matrix metalloproteinases affecting the prognosis and immunogenic profile of gastric cancer

  2023cites this paper
• Pathophysiological roles of thrombospondin-4 in disease development.

  2023cites this paper
• Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas

  2023influential citation
• Identification of a six-gene signature to predict survival and immunotherapy effectiveness of gastric cancer

  2023cites this paper
• Thrombospondins in the tumor microenvironment.

  2023cites this paper
• Clinically conserved genomic subtypes of gastric adenocarcinoma

  2023cites this paper
• A thirty-three gene-based signature predicts lymph node metastasis and prognosis in patients with gastric cancer

  2023cites this paper
• Skeletal muscle omics signatures in cancer cachexia: perspectives and opportunities.

  2023cites this paper
• Spatial dissection of cellular heterogeneity and functional crosstalk in the tumor microenvironments of gastric cancers

  2023cites this paper
• Evaluating the Robustness of Connectivity Methods to Noise for In Silico Drug Repurposing Studies

  2022cites this paper
• A nine–consensus–prognostic –gene–based prognostic signature, recognizing the dichotomized subgroups of gastric cancer patients with different clinical outcomes and therapeutic strategies

  2022cites this paper
• Accurate prediction of stomach adenocarcinomas of poorest and best prognosis with a combination of gene expression and clinical signatures

  2022cites this paper
• Artificial intelligence-guided discovery of gastric cancer continuum

  2022cites this paper
• High Expression of PRNP Predicts Poor Prognosis in Korean Patients with Gastric Cancer

  2022cites this paper
• IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYC axis

  2022cites this paper
• Identification of a potential competing endogenous RNA (ceRNA) network in gastric adenocarcinoma

  2022cites this paper
• Development and validation of an RNA-seq-based transcriptomic risk score for asthma

  2022cites this paper
• Comprehensive Landscape of STEAP Family Members Expression in Human Cancers: Unraveling the Potential Usefulness in Clinical Practice Using Integrated Bioinformatics Analysis

  2022cites this paper
• Prognostic and Immunological Value of GNB4 in Gastric Cancer by Analyzing TCGA Database

  2022cites this paper
• An integrative approach toward identification and analysis of therapeutic targets involved in HPV pathogenesis with a focus on carcinomas

  2022cites this paper
• TEADs serve as potential prognostic biomarkers and targets for human gastric cancer

  2022cites this paper
• CBXs-related prognostic gene signature correlates with immune microenvironment in gastric cancer

  2022cites this paper
• GGT5 Is an Independent Prognostic Biomarker in Stomach Adenocarcinoma

  2022influential citation
• A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy

  2022cites this paper
• TWIST1-EP300 Expedites Gastric Cancer Cell Resistance to Apatinib by Activating the Expression of COL1A2

  2022influential citation
• Circulating exosomal gastric cancer-associated long noncoding RNA1 as a noninvasive biomarker for predicting chemotherapy response and prognosis of advanced gastric cancer: A multi-cohort, multi-phase study

  2022cites this paper
• Identification and validation of critical genes with prognostic value in gastric cancer

  2022cites this paper
• Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets

  2022cites this paper
• PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer

  2022cites this paper
• Identifying Diagnostic and Prognostic Differentially Expressed Genes of Gastric Cancer Based on Bioinformatics Analyses of RNA-seq Data

  2022cites this paper
• Crosstalk of Histone and RNA Modifications Identified a Stromal-Activated Subtype with Poor Survival and Resistance to Immunotherapy in Gastric Cancer

  2022cites this paper
• High expression of SMARCC1 predicts poor prognosis in gastric cancer patients.

  2022influential citation
• A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma

  2022cites this paper
• Identification of ARGLU1 as a potential therapeutic target for gastric cancer based on genome-wide functional screening data

  2021cites this paper
• Multidimensional study of cell division cycle-associated proteins with prognostic value in gastric carcinoma

  2021influential citation
• The Pyroptosis-Related Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Gastric Cancer

  2021cites this paper
• Comprehensive Analysis of SFRP Family Members Prognostic Value and Immune Infiltration in Gastric Cancer

  2021cites this paper
• Evaluation of the prognostic value of CBXs in gastric cancer patients

  2021cites this paper
• Serine/threonine-protein kinase 24 is an inhibitor of gastric cancer metastasis

  2021cites this paper
• Diagnostic, Therapeutic, and Prognostic Value of the Thrombospondin Family in Gastric Cancer

  2021cites this paper
• Comprehensive Analysis and Identification of Prognostic Biomarkers and Therapeutic Targets Among FAM83 Family Members for Gastric Cancer

  2021cites this paper
• Clonal Architectures Predict Clinical Outcome in Gastric Adenocarcinoma Based on Genomic Variation, Tumor Evolution, and Heterogeneity

  2021cites this paper
• BMPR2 expression level is correlated with low immune infiltration and predicts metastasis and poor survival in osteosarcoma

  2021cites this paper
• ENTREP/FAM189A2 encodes a new ITCH ubiquitin ligase activator that is downregulated in breast cancer

  2021cites this paper
• Serine/threonine-protein kinase 24 is an inhibitor of gastric cancer metastasis through suppressing CDH1 gene and enhancing stemness.

  2021cites this paper
• Toll-like receptor 3 is a potential prognosis marker and associated with immune infiltration in stomach adenocarcinoma

  2021cites this paper
• Comprehensive bioinformatics analyses identified Homeobox B9 as a potential prognostic biomarker and therapeutic target for gastric cancer.

  2021influential citation
• PLXDC1 May Serve As A Target For Combining Antiangiogenic Therapy and Immunotherapy In Gastric Adenocarcinoma

  2021cites this paper
• Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer

  2021cites this paper
• High expression of PIG11 correlates with poor prognosis in gastric cancer

  2021influential citation
• An Integrated Analysis of The Prognosis And Immune Cell Infiltration of ITGB Superfamily Members In Gastric Cancer

  2021cites this paper
• Comprehensive Analysis of E2F Family Members in Human Gastric Cancer

  2021cites this paper
• Exploration of Lipid Metabolism in Gastric Cancer: A Novel Prognostic Genes Expression Profile

  2021influential citation
• Knockdown of CENPK inhibits cell growth and facilitates apoptosis via PTEN‐PI3K‐AKT signalling pathway in gastric cancer

  2021cites this paper
• Meta-Analysis Reveals the Prognostic Relevance of Nuclear and Membrane-Associated Bile Acid Receptors in Gastric Cancer

  2021cites this paper
• Comprehensive molecular characterization and identification of prognostic signature in stomach adenocarcinoma on the basis of energy-metabolism-related genes

  2021cites this paper
• Multidimensional study of CDCA family members in gastric carcinoma with prognostic value

  2021cites this paper
• Thrombospondin-4 Is a Soluble Dermal Inflammatory Signal That Selectively Promotes Fibroblast Migration and Keratinocyte Proliferation for Skin Regeneration and Wound Healing

  2021cites this paper
• Comprehensive Analysis of the Prognostic Value of ITGB Superfamily Members in Gastric Cancer Using Bioinformatics Analysis

  2021cites this paper
• The tweety Gene Family: From Embryo to Disease

  2021cites this paper
• Construction and Validation of a Novel Prognostic Signature for Intestinal Type of Gastric Cancer

  2021cites this paper
• TMEM2 binds to CSNK2A3 to inhibit HBV infection via activation of the JAK/STAT pathway.

  2021cites this paper
• Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers

  2021cites this paper
• Estrogen-related receptor-gamma influences Helicobacter pylori infection by regulating TFF1 in gastric cancer.

  2021cites this paper
• Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer

  2021influential citation
• Targeting the histone demethylase PHF8-mediated PKCα-Src-PTEN axis in HER2-negative gastric cancer

  2020cites this paper
• Identification of a nine-gene prognostic signature for gastric carcinoma using integrated bioinformatics analyses

  2020cites this paper